Viewing Study NCT00518895

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:03 PM
Ignite Modification Date: 2026-01-03 @ 9:30 AM
Study NCT ID: NCT00518895
Status: COMPLETED
Last Update Posted: 2011-11-07
First Post: 2007-08-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Trial of Dacarbazine With or Without Genasense in Advanced Melanoma
Sponsor: Genta Incorporated
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Melanoma View
None Advanced Melanoma View
None Malignant Melanoma View
None Metastatic Melanoma View
None Skin Cancer View
None Genasense View
None oblimersen View
None antisense View
None Bcl-2 antisense View
None G3139 View
None dacarbazine View